Menu

Pharma News

picture 80

Teva and Takeda partner for generics in Japan

Home/Pharma News | Posted 11/12/2015

Israeli generics giant Teva Pharmaceutical Industries (Teva) and Japan-based Takeda Pharmaceutical (Takeda) announced on 30 November 2015 that they had made a partnership to provide generics in Japan.

picture 63

Generic injectable prices stay high even after shortages resolved

Home/Pharma News | Posted 27/11/2015

Hospitals that have been struggling with shortages and subsequent high prices are now complaining that even after supply gets back to normal prices remain high. 

2014 shutterstock 233120428

Mylan will not be acquiring Perrigo

Home/Pharma News | Posted 20/11/2015

Generics company Mylan has failed in its lengthy multi-billion dollar hostile bid to acquire competing generics company Perrigo.

Pfizer cuts some biosimilars after Hospira deal

Home/Pharma News | Posted 13/11/2015

After completing its US$17 billion acquisition of Hospira, Pfizer is cutting some of its biosimilar collaborations with South Korean drugmaker Celltrion.

Shaking hands V13D29

Merck Millipore to collaborate with Turkish firm on biosimilars

Home/Pharma News | Posted 06/11/2015

The Life Science division of Merck, Merck Millipore and Turkish biosimilars start-up Turgut Ilaç are to collaborate on biosimilars.

122 MD002454

Teva acquires Mexican drugmaker Rimsa

Home/Pharma News | Posted 16/10/2015

Israeli generics giant Teva Pharmaceutical Industries (Teva) is expanding its presence in emerging markets with its acquisition of Mexico-based Representaciones e Investigaciones Medicas SA de CV (Rimsa), a specialty drugmaker with a portfolio of products and patents across Latin America.

Shaking hands V13D29

Mylan goes after Perrigo

Home/Pharma News | Posted 09/10/2015

US generics manufacturer Mylan announced on 14 September 2015 that it had officially commenced its formal offer to acquire all outstanding ordinary shares of rival Ireland-based generics maker Perrigo Company (Perrigo).

Business Aquisition V13F07

Epirus expands biosimilars pipeline with Bioceros acquisition

Home/Pharma News | Posted 02/10/2015

US-based Epirus Biopharmaceuticals (Epirus) announced on 9 September 2015 that it has acquired Netherlands-based biopharmaceutical company Bioceros Holding (Bioceros).

Generics Blue Cap V13C15

UCB sells generics unit to Lannett

Home/Pharma News | Posted 11/09/2015

Belgium-based biopharmaceutical company UCB announced on 2 September 2015 that it would sell its US specialty generics business, Kremers Urban, to US generics company Lannett for US$1.23 billion in cash plus contingent payments.

Shaking hands V13D29

US FTC clears Pfizer’s purchase of Hospira

Home/Pharma News | Posted 04/09/2015

Pharma giant Pfizer announced on 24 August 2015 that the US Federal Trade Commission (FTC) terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to Pfizer’s pending acquisition of US-based injectable generics specialist and biosimilars maker Hospira.

Australia flag V13C29

ANI Pharma and IDT Australia collaborate on US generics

Home/Pharma News | Posted 28/08/2015

US-based brand-name and generic drugmaker ANI Pharmaceuticals (ANI) announced on 12 August 2015 that it had entered into a collaboration with generics company IDT Australia (IDT) to commercialize up to 18 previously marketed US generics.

picture 66

Mergers between Watson/Actavis and ANI Pharma/BioSante

Home/Pharma News | Posted 19/10/2012

Mergers are once again on the agenda as companies strive to meet the constant demands of governments to cut costs and yet still make a profit.

Shaking hands V13D29

AstraZeneca and Fujifilm Kyowa Kirin Biologics to collaborate on bevacizumab biosimilar

Home/Pharma News | Posted 21/08/2015

Japanese biosimilars maker Fujifilm Kyowa Kirin Biologics announced on 24 July 2015 that it had entered into an agreement with pharma giant AstraZeneca to establish a joint venture for the development and commercialization of its candidate biosimilar, FKB238.

picture 84

Hikma to acquire Boehringer Ingelheim’s US generics business

Home/Pharma News | Posted 21/08/2015

Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) announced on 28 July 2015 that it had made a deal with Germany’s Boehringer Ingelheim to acquire the latter’s US generics business: Roxane Laboratories and Boehringer Ingelheim Roxane (Roxane).

Shaking hands V13D29

Lupin to expand US generics business with Gavis acquisition

Home/Pharma News | Posted 07/08/2015

Indian generics manufacturer Lupin Pharmaceuticals (Lupin) announced on 23 July 2015 that it had entered into a definitive agreement to acquire US generics makers Gavis Pharmaceuticals and Novel Laboratories (Gavis).

Shaking hands V13D29

Acquisitions for Endo and Strides

Home/Pharma News | Posted 26/06/2015

Endo Pharmaceuticals (Endo) and Strides Arcolab (Strides) are both looking at acquisitions as a way to expand their generics businesses.

Shaking hands V13D29

Amneal to acquire Australian generics business from Actavis

Home/Pharma News | Posted 15/05/2015

Privately held US generics maker Amneal Pharmaceuticals (Amneal) announced on 31 March 2015 that it had made a deal with the Australian subsidiary of Actavis to acquire the Australian generics business of Actavis for an undisclosed amount.

88 MD002468

Anticompetitive acquisition forces generics sale

Home/Pharma News | Posted 08/05/2015

US generics maker CorePharma has had to sell its rights of two generics in order to merge with fellow US drug company Impax Laboratories (Impax). The US Federal Trade Commission (FTC) ruled that Impax’s acquisition of CorePharma would have been anticompetitive unless CorePharma sold its rights and assets for pilocarpine, a drug used to treat dry mouth and glaucoma, and ursodiol, a treatment for liver and gall bladder diseases.

Teva finally makes bid for Mylan

Home/Pharma News | Posted 04/05/2015

In the wake of many rumours, Israeli generics giant Teva Pharmaceutical Industries (Teva) finally announced on 21 April 2015 that it had made a bid for US-based generics maker Mylan.

07 AA011110

Growing investment in Vietnam

Home/Pharma News | Posted 27/04/2015

Cyprus-based generics company Medochemie is building its second factory in Vietnam. Construction on the site, which will occupy 44,700 square metres, is expected to be completed by the end of 2015 with operations commencing in early 2016.